NCT02044692View on ClinicalTrials.gov

The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients

UnknownOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Hunter Syndrome
Trial Locations (1)

Unknown

RECRUITING

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY